Assessing Fracture Risk in Sarcopenic Type 2 Diabetes (T2DM) Patients: A Cross-sectional Study in A Tertiary Care Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250216003

Enrollment

250

Registered

2025-02-16

Start date

2025-02-07

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture risk in Type 2 diabetes (T2DM) patients with or without sarcopenia Diabetes, Sarcopenia, Fracture risk

Interventions

Outpatients aged 40-90, diagnosed with Type 2 diabetes for over a year, able to walk and stand independently, and diagnosed with sarcopenia according to AWGS 2019.,Outpatients aged 40-90, diagnosed wi

Screening,Screening

Type 2 diabetes with sarcopenia,Type 2 diabetes without sarcopenia

Eligibility

Sex/Gender

All

Age

40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-90 years, 2.Diagnosed with type 2 diabetes for more than 1 year, 3. Able to walk and stand independently without the use of assistive devices

Exclusion criteria

Exclusion criteria: 1. Patients with type 1 diabetes and other types of diabetes, 2. History of fragility fractures, 3. Diagnosed with osteoporosis or receiving treatment for osteoporosis, 4. Chronic kidney disease stage 4-5 (eGFR less than 30 ml/min/1.73m2), 5. Chronic liver disease, 6. Gastrointestinal malabsorption, 7. Active malignancy, 8. Rheumatoid arthritis, 9. Autoimmune diseases, 10. Illicit drug users, 11. Non-consenting individuals, 12. Patients with fatigue, balance, or mobility issues that risk falling during testing, 13. Patients contraindicated for Bioelectrical Impedance Analysis (BIA)

Design outcomes

Primary

Measure	Time frame
FRAX without BMD at study point Thai FRAX score	—

Secondary

Measure	Time frame
Prevalence of sarcopenia among T2DM patients at study point Sarcopenia diagnosed based on muscle mass, strength, and physical performance, including the 6-meter walk test and the 5-time chair stand test.,Risk factors associated with sarcopenia in T2DM patients at study point Risk factors associated with sarcopenia in T2DM patients evaluated using demographic data, laboratory results, and information from interviews and medical records.	—

Measure

Time frame

Prevalence of sarcopenia among T2DM patients at study point Sarcopenia diagnosed based on muscle mass, strength, and physical performance, including the 6-meter walk test and the 5-time chair stand test.,Risk factors associated with sarcopenia in T2DM patients at study point Risk factors associated with sarcopenia in T2DM patients evaluated using demographic data, laboratory results, and information from interviews and medical records.

—

Countries

Thailand

Contacts

Public ContactPitchaporn Phudphong

Faculty of Medicine, Vajira hospital, Navamindradhiraj University

pitchaproud@gmail.com0830077656

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026